BioM specializes in the production, development, and distribution of radiopharmaceuticals
0+
Business Year
Established in 2005, Bio Molecular Industries Sdn. Bhd. (BioM) operating as Curium Malaysia
0+
Quality Control
All operations are conducted in strict compliance with international GMP standards, HPLC, GC, TLC and etc.
0+
Clients in Malaysia
Serving a network of majority PET/CT centers across Malaysia. Regional footprints with exports and growing.
02. What We Do
BioM specializes in the production, development, and distribution of radiopharmaceuticals
Positron Emission Tomography (PET) imaging, Oncology diagnostics and treatment Theranostics (combined diagnostic and therapeutic solutions), Brachytherapy applications, Fluorodeoxyglucose (FDG) – widely used in cancer imaging, Emerging PET tracers.
BioM's end-to-end radiopharmaceutical Production process
Radioisotope Generation using cyclotron technology Automated Synthesis via advanced platforms such as Trasis Aseptic Dispensing with precision dose fractionation systems Comprehensive Quality Control & Assurance using HPLC, GC, TLC, and other analytical tools All operations are conducted in strict compliance with international GMP standards, ensuring patient safety and product integrity.
To be the leading nuclear medicine partner in Southeast Asia, delivering innovative radiopharmaceutical solutions that improve patient outcomes and expand access to advanced diagnostics and therapies.
05. Our Achievements
Beyond Execellence
Proven on-time delivery performance (92–97%) since 2015
Regional footprint with exports, including supply to Myanmar
First GMP-Certified PET radiopharmaceutical producer in Malaysia
Market leader in PET radiopharmaceutical supply
Serving a network of majority PET/CT centers across Malaysia